Health In Tech (NASDAQ:HIT) Releases Earnings Results, Beats Estimates By $0.01 EPS

Health In Tech (NASDAQ:HIT) posted its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. The business had revenue of $8.77 million during the quarter.

Here are the key takeaways from Health In Tech’s conference call:

• Health In Tech reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, implying roughly 35% to 50% year-over-year growth as the company continues to invest in expansion.
• First-quarter revenue was $8.8 million, up about 9% from last year, but adjusted EBITDA turned negative $1.3 million as spending increased on sales, marketing, and product development.
• The company introduced new reporting metrics: contracted revenue of about $22.9 million for the rest of 2026 and platform placed plan value of $82 million in Q1, which management said gives better visibility into future revenue.
• Management is stepping up investment in distribution, carrier partnerships, and AI-enabled technology, including a new AWS-related development effort and a more proactive broker go-to-market strategy.
• The company highlighted strong early interest in its three-year rate stabilization program and said it is on track for market testing later in 2Q into 3Q 2026, with no upfront deposit required from customers.

Health In Tech Trading Up 1.3%

Shares of NASDAQ HIT opened at $1.54 on Thursday. The stock has a 50 day simple moving average of $1.59 and a 200-day simple moving average of $1.56. Health In Tech has a 12-month low of $0.56 and a 12-month high of $4.02. The company has a market cap of $92.34 million, a PE ratio of 77.00 and a beta of 3.67.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HIT. Craig Hallum initiated coverage on Health In Tech in a report on Monday, April 20th. They issued a “buy” rating and a $4.00 target price for the company. Wall Street Zen cut Health In Tech from a “hold” rating to a “sell” rating in a research report on Saturday, April 25th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Health In Tech in a report on Thursday, April 2nd. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Health In Tech has a consensus rating of “Buy” and an average price target of $3.25.

Institutional Investors Weigh In On Health In Tech

Institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC grew its holdings in shares of Health In Tech by 46.6% in the 4th quarter. Geode Capital Management LLC now owns 170,502 shares of the company’s stock worth $271,000 after acquiring an additional 54,217 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Health In Tech in the fourth quarter valued at about $214,000. XTX Topco Ltd bought a new position in shares of Health In Tech in the fourth quarter worth about $203,000. Ancora Advisors LLC acquired a new position in shares of Health In Tech during the third quarter valued at about $389,000. Finally, Two Sigma Investments LP acquired a new position in shares of Health In Tech in the third quarter valued at $386,000.

Health In Tech Company Profile

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.